While PD-1 blockers were effective only in early tumor stages, PD-1/PDL-1 pathway is inhibited by T. gondii during both early and chronic infection stages, which potentiates its use in early and late tumor stages [44]. This evidence concerns the gene CD274 and neoplasm.